ClinicalTrials.Veeva

Menu

IDH1 and OCT4 in High Grade Astrocytoma

A

Assiut University

Status

Enrolling

Conditions

High Grade Astrocytoma

Treatments

Other: biomarkers analysis

Study type

Observational

Funder types

Other

Identifiers

NCT06214689
biomarkers in astrocytoma

Details and patient eligibility

About

observation of IDH1 and OCT4 markers level and high grade astrocytoma patients prognosis after excision.

Full description

explore the relationship between prognosis and IDH1 and OCT4 biomarkers after high grade astrocytoma excision , according to progression free survival and overall survival , in prospective and retrospective samples.

Enrollment

35 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients of high grade astrocytic glioma patients fit for surgery

Exclusion criteria

  • patients of low grade glioma patients unfit for surgery

Trial contacts and locations

1

Loading...

Central trial contact

Abdelrahman A Salama, resident; Mahmoud H Ragab, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems